In vivo analysis of demyelination and remyelination in an animal ...
In contrast, Chrm1 null EAE mice displayed a moderately reduced disease severity from the earliest stages of disease, followed by a remission ...
CPT1A plays a key role in the development and treatment of multiple ...Refining studies using animal models could serve as a key strategy to enhance the translation of research findings to clinical stages [4]. Tonabersat Significantly Reduces Disease Progression in an ...The EAE mice were perfused at maximum EAE clinical severity with clinical scores of 3-3.5 (14-16 days post-immunization). Brains were extracted and post-fixed ... IC100: a novel anti-ASC monoclonal antibody improves functional ...Statistical analysis was performed using the 2-tailed Fisher exact probability test for incidence and the Wilcoxon rank sum test for clinical.
Autres Cours:
